Literature DB >> 21829137

An epidemiologic surveillance of Shiga-like toxin-producing Escherichia coli infection in Argentinean children: risk factors and serum Shiga-like toxin 2 values.

Eduardo L López1, Maria M Contrini, Eduardo Glatstein, Silvia González Ayala, Roberto Santoro, Gustavo Ezcurra, Eduardo Teplitz, Yoichi Matsumoto, Hiroaki Sato, Kazuaki Sakai, Yasuhiro Katsuura, Satoru Hoshide, Takuya Morita, Ronald Harning, Sheldon Brookman.   

Abstract

BACKGROUND AND AIMS: Shiga-like toxin (Stx)-producing Escherichia coli (STEC) infection is an ongoing health issue that can lead to serious complications, including hemolytic uremic syndrome (HUS) and death. This study assessed demographic and epidemiologic information of STEC infection among Argentinean children.
METHODS: A prospective surveillance of 2435 screened children (age, 0.5-15 years) presenting with watery diarrhea and/or bloody diarrhea was undertaken to evaluate the clinical course of STEC infection.
RESULTS: Prevalence of STEC infection was 4.1% among subjects presenting with watery diarrhea for ≤ 5 days' duration, bloody diarrhea for ≤ 36 hours' duration, or both. Incidence of STEC infection was significantly higher in the subjects with bloody diarrhea. Ninety-three STEC+ children underwent further evaluation, of whom 8 (8.6%) developed HUS. White blood cells, particularly neutrophils, were abnormally elevated at screening in 5 of 8 HUS subjects. Quantifiable serum Stx-2 values were noted within 24 to 48 hours after the onset of bloody diarrhea in 3 HUS subjects using a validated chemiluminescence assay, with levels quickly dissipating by HUS onset.
CONCLUSIONS: Results suggest that young STEC-positive children with bloody diarrhea and exhibiting neutrophilic leukocytosis in the early course of their diarrhea are at risk for HUS progression. The observation of measurable concentrations of Stx-2 levels in the early post-bloody-diarrhea period and rapid dissipation at the time of HUS onset requires further evaluation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21829137     DOI: 10.1097/INF.0b013e31822ea6cf

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  19 in total

1.  Serodiagnosis using microagglutination assay during the food-poisoning outbreak in Japan caused by consumption of raw beef contaminated with enterohemorrhagic Escherichia coli O111 and O157.

Authors:  Junko Isobe; Tomoko Shima; Jun-Ichi Kanatani; Keiko Kimata; Miwako Shimizu; Naoto Kobayashi; Tomoko Tanaka; Sunao Iyoda; Makoto Ohnishi; Tetsutaro Sata; Masanori Watahiki
Journal:  J Clin Microbiol       Date:  2014-01-22       Impact factor: 5.948

2.  Dysregulation of angiopoietin 1 and 2 in Escherichia coli O157:H7 infection and the hemolytic-uremic syndrome.

Authors:  Andrea V Page; Phillip I Tarr; Sandra L Watkins; Nimerta Rajwans; Tania N Petruzziello-Pellegrini; Philip A Marsden; Kevin C Kain; W Conrad Liles
Journal:  J Infect Dis       Date:  2013-06-24       Impact factor: 5.226

Review 3.  Global incidence of human Shiga toxin-producing Escherichia coli infections and deaths: a systematic review and knowledge synthesis.

Authors:  Shannon E Majowicz; Elaine Scallan; Andria Jones-Bitton; Jan M Sargeant; Jackie Stapleton; Frederick J Angulo; Derrick H Yeung; Martyn D Kirk
Journal:  Foodborne Pathog Dis       Date:  2014-04-21       Impact factor: 3.171

4.  Effects of Shiga toxin type 2 on a bioengineered three-dimensional model of human renal tissue.

Authors:  Teresa M DesRochers; Erica Palma Kimmerling; Dakshina M Jandhyala; Wassim El-Jouni; Jing Zhou; Cheleste M Thorpe; John M Leong; David L Kaplan
Journal:  Infect Immun       Date:  2014-10-13       Impact factor: 3.441

5.  Predicting Hemolytic Uremic Syndrome and Renal Replacement Therapy in Shiga Toxin-producing Escherichia coli-infected Children.

Authors:  Ryan S McKee; David Schnadower; Phillip I Tarr; Jianling Xie; Yaron Finkelstein; Neil Desai; Roni D Lane; Kelly R Bergmann; Ron L Kaplan; Selena Hariharan; Andrea T Cruz; Daniel M Cohen; Andrew Dixon; Sriram Ramgopal; Annie Rominger; Elizabeth C Powell; Jennifer Kilgar; Kenneth A Michelson; Darcy Beer; Martin Bitzan; Christopher M Pruitt; Kenneth Yen; Garth D Meckler; Amy C Plint; Stuart Bradin; Thomas J Abramo; Serge Gouin; April J Kam; Abigail Schuh; Fran Balamuth; Tracy E Hunley; John T Kanegaye; Nicholas E Jones; Usha Avva; Robert Porter; Daniel M Fein; Jeffrey P Louie; Stephen B Freedman
Journal:  Clin Infect Dis       Date:  2020-04-10       Impact factor: 9.079

6.  Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis.

Authors:  Craig S Wong; Jody C Mooney; John R Brandt; Amy O Staples; Srdjan Jelacic; Daniel R Boster; Sandra L Watkins; Phillip I Tarr
Journal:  Clin Infect Dis       Date:  2012-03-19       Impact factor: 9.079

7.  Bimodal Response to Shiga Toxin 2 Subtypes Results from Relatively Weak Binding to the Target Cell.

Authors:  Patrick Cherubin; Dennis Fidler; Beatriz Quiñones; Ken Teter
Journal:  Infect Immun       Date:  2019-11-18       Impact factor: 3.441

8.  Quiescent complement in nonhuman primates during E coli Shiga toxin-induced hemolytic uremic syndrome and thrombotic microangiopathy.

Authors:  Benjamin C Lee; Chad L Mayer; Caitlin S Leibowitz; D J Stearns-Kurosawa; Shinichiro Kurosawa
Journal:  Blood       Date:  2013-06-03       Impact factor: 22.113

Review 9.  The interactions of human neutrophils with shiga toxins and related plant toxins: danger or safety?

Authors:  Maurizio Brigotti
Journal:  Toxins (Basel)       Date:  2012-03-01       Impact factor: 4.546

Review 10.  Haemolytic-uraemic syndrome as a sequela of diarrhoeal disease.

Authors:  Christa L Fischer Walker; Jennifer A Applegate; Robert E Black
Journal:  J Health Popul Nutr       Date:  2012-09       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.